| Name: | Alogliptin benzoate |
|---|---|
| CAS:: | 850649-62-6 |
| Molecular Formula: | C25H27N5O4 |
| Standard: | In-house |
| Documentation: | CDMF |
| Development stage: | Commercialization |
Alogliptin benzoate
Alogliptin Benzoate is the benzoate salt form of alogliptin, a selective, orally bioavailable, pyrimidinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. In addition to its effect on glucose levels, alogliptin may inhibit inflammatory responses by preventing the toll-like receptor 4 (TLR-4)-mediated formation of proinflammatory cytokines.